USPTO serial 79294318
IPS STOCK
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 1, 2022
- Examiner
- CLAYTON, CHERYL A
- Law office
- TMEG LAW OFFICE 102
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with IPS STOCK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*
Plus Government fees of $1,625
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Dawn Rudenko
Dawn Rudenko Holland & Knight LLP263 Tresser BlvdOne Stamford Plaza, Ste1400Stamford, CT 06901Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research and scientific purposes; stem cells, other than for medical or veterinary purposes; chemicals used in industry; plant growth regulating preparations; fertilizers; chemical test paper, other than for medical purposes | ACTIVE | — |
| 005 | Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paper, namely, reagent paper for medical purposes | ACTIVE | — |
| 039 | Storage of frozen living cells; storage of tissues, cells and stem cells; warehousing services for deposited articles | ACTIVE | — |
| 042 | Research in the field of stem cells; commissioned cell cultures for scientific purposes, namely, custom design and development of cell cultures for scientific use; cell or gene examination in the nature of research on cells and genes; testing and examination on cells; research and development in the field of cells; testing, examination, research and development in the field of regenerative medicine; testing, examination, research and development of pharmaceuticals; scientific research in the field of culture of cells for transplantation collected from a patient itself; clinical study in the medical field; providing quality assurance services in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on testing, inspection, or research related to medical science using stem cells; providing information related to research and development of pharmaceutical preparations; scientific testing, analysis, or research on treatment method and treatment technique related to medical care; testing, inspection or research of cosmetics or foods; design and development of computer hardware and computer software for use in the field of medical science; designing of machines, apparatus, instruments, including their parts, or systems composed of such machines, apparatus and instruments; design, development or maintenance of computer programs; testing the functionality of machines, apparatus, and instruments or research on machines apparatus, and instruments; rental of laboratory apparatus and instruments | ACTIVE | — |
| 044 | Stem cell therapy; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissues, blood and cells; medical treatment and diagnosis in the nature of regenerative therapy by culture of medical and clinical cells; medical care; providing information and data for diagnosis and medical treatment in the nature of medical information; medical treatment or diagnosis in the nature of regenerative therapy using regenerative medicine; medical treatment or diagnosis in the nature of regenerative cell therapy; medical treatment in the nature of regenerative therapy; professional medical consulting services in the field of cell preparations to treat diseases; preservation of human blood for use as a supply source of stem cells; clinical examination in the nature of medical examination services; provision of patient clinical medical information and medical record analysis for use in medical treatment, diagnosis and prevention; medical treatment in the nature of regenerative therapy using cultured cells; [ preparation and dispensing of medications; ] physical examination services; [ dentistry services; ] providing health information; dietary and nutritional guidance; rental of medical apparatus; commissioned cell culture services for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CiRA Foundation
- Other trademarks owned by CiRA Foundation
- Other trademarks owned by CiRA Foundation
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named IPS STOCK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 5, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 15, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 15, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 18, 2022 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jul 15, 2022 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 1, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 25, 2022 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 1, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 29, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 26, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 16, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 16, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 27, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 27, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 27, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 8, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 5, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 5, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 11, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 13, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 12, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 12, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 12, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 27, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 9, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 19, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 19, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 2, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 29, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |